Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease.
Bioorg Med Chem Lett. 2018 Jun 1;28(10):1846-1848. doi: 10.1016/j.bmcl.2018.04.010. Epub 2018 Apr 19.
Bioorg Med Chem Lett. 2018.
PMID: 29691139
Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin.
Kahlon G, Lira R, Masvlov N, Pompa E, Brar N, Eagon S, Anderson MO, Andaya A, Chance JP, Fejzic H, Keniston A, Huynh N, Celis N, Vidal B, Trieu N, Rodriguez P, Mallari JP.
Kahlon G, et al. Among authors: chance jp.
Bioorg Med Chem Lett. 2021 Jan 15;32:127683. doi: 10.1016/j.bmcl.2020.127683. Epub 2020 Nov 20.
Bioorg Med Chem Lett. 2021.
PMID: 33227414
Free article.
Item in Clipboard
Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].
Kahlon G, Lira R, Masvlov N, Pompa E, Brar N, Eagon S, Anderson MO, Andaya A, Chance JP, Fejzic H, Keniston A, Huynh N, Celis N, Vidal B, Trieu N, Rodriguez P, Mallari JP.
Kahlon G, et al. Among authors: chance jp.
Bioorg Med Chem Lett. 2021 Apr 1;37:127836. doi: 10.1016/j.bmcl.2021.127836. Epub 2021 Feb 13.
Bioorg Med Chem Lett. 2021.
PMID: 33588181
Free article.
No abstract available.
Item in Clipboard
Cite
Cite